EMT is a vital process contributing to cervical cancer progression, invasion and metastasis and characterized by the loss of epithelial markers, such as E-cadherin, and the gain of mesenchymal markers, such as N-cadherin and vimentin [45]. The gene discussed is CDH2; the disease is cervical carcinoma.